Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Mitogen Activated Protein Kinase 14 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Mitogen Activated Protein Kinase 14market, defines the market attractiveness level of Mitogen Activated Protein Kinase 14 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Mitogen Activated Protein Kinase 14 industry, describes the types of Mitogen Activated Protein Kinase 14 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mitogen Activated Protein Kinase 14 market and the development prospects and opportunities of Mitogen Activated Protein Kinase 14 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mitogen Activated Protein Kinase 14 market in Chapter 13.
By Player:
Chroma Therapeutics Limited
Toray Industries
Eli Lilly and Company
Zocere, Inc
Array BioPharma Inc
Astellas Pharma Inc
GlaxoSmithKline Plc
Synovo GmbH
AstraZeneca Plc
Chiesi Farmaceutici SpA
By Type:
Ralimetinib Mesylate
Losmapimod
Neflamapimod
CHF-6297
Others
By End-User:
Chronic Inflammation
Ulcerative Colitis
Epithelial Ovarian Cancer
Gastric Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Mitogen Activated Protein Kinase 14 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Mitogen Activated Protein Kinase 14 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Mitogen Activated Protein Kinase 14 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Mitogen Activated Protein Kinase 14 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Mitogen Activated Protein Kinase 14 Market Analysis and Outlook to 2022
-
7.1 Global Mitogen Activated Protein Kinase 14 Consumption (2017-2022)
-
7.2 United States Mitogen Activated Protein Kinase 14 Consumption (2017-2022)
-
7.3 Europe Mitogen Activated Protein Kinase 14 Consumption (2017-2022)
-
7.4 China Mitogen Activated Protein Kinase 14 Consumption (2017-2022)
-
7.5 Japan Mitogen Activated Protein Kinase 14 Consumption (2017-2022)
-
7.6 India Mitogen Activated Protein Kinase 14 Consumption (2017-2022)
-
7.7 South Korea Mitogen Activated Protein Kinase 14 Consumption (2017-2022)
8 Region and Country-wise Mitogen Activated Protein Kinase 14 Market Analysis and Outlook to 2028
-
8.1 Global Mitogen Activated Protein Kinase 14 Consumption Forecast (2022-2028)
-
8.2 United States Mitogen Activated Protein Kinase 14 Consumption Forecast (2022-2028)
-
8.3 Europe Mitogen Activated Protein Kinase 14 Consumption Forecast (2022-2028)
-
8.4 China Mitogen Activated Protein Kinase 14 Consumption Forecast (2022-2028)
-
8.5 Japan Mitogen Activated Protein Kinase 14 Consumption Forecast (2022-2028)
-
8.6 India Mitogen Activated Protein Kinase 14 Consumption Forecast (2022-2028)
-
8.7 South Korea Mitogen Activated Protein Kinase 14 Consumption Forecast (2022-2028)
9 Global Mitogen Activated Protein Kinase 14 Market Outlook by Types and Applications to 2022
-
9.1 Global Mitogen Activated Protein Kinase 14 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ralimetinib Mesylate Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Losmapimod Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Neflamapimod Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CHF-6297 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Mitogen Activated Protein Kinase 14 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chronic Inflammation Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Epithelial Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Gastric Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Mitogen Activated Protein Kinase 14 Market Outlook by Types and Applications to 2028
-
10.1 Global Mitogen Activated Protein Kinase 14 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ralimetinib Mesylate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Losmapimod Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Neflamapimod Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CHF-6297 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Mitogen Activated Protein Kinase 14 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chronic Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Epithelial Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Mitogen Activated Protein Kinase 14 Import and Export Analysis (Top 5 Countries)
-
11.1 Global Mitogen Activated Protein Kinase 14 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Mitogen Activated Protein Kinase 14 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Mitogen Activated Protein Kinase 14 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Mitogen Activated Protein Kinase 14 Market Competitive Analysis
-
14.1 Chroma Therapeutics Limited
-
14.1.1 Chroma Therapeutics Limited Company Details
-
14.1.2 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product and Service
-
14.2 Toray Industries
-
14.2.1 Toray Industries Company Details
-
14.2.2 Toray Industries Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Toray Industries Mitogen Activated Protein Kinase 14 Product and Service
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Details
-
14.3.2 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product and Service
-
14.4 Zocere, Inc
-
14.4.1 Zocere, Inc Company Details
-
14.4.2 Zocere, Inc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Zocere, Inc Mitogen Activated Protein Kinase 14 Product and Service
-
14.5 Array BioPharma Inc
-
14.5.1 Array BioPharma Inc Company Details
-
14.5.2 Array BioPharma Inc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Array BioPharma Inc Mitogen Activated Protein Kinase 14 Product and Service
-
14.6 Astellas Pharma Inc
-
14.6.1 Astellas Pharma Inc Company Details
-
14.6.2 Astellas Pharma Inc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Astellas Pharma Inc Mitogen Activated Protein Kinase 14 Product and Service
-
14.7 GlaxoSmithKline Plc
-
14.7.1 GlaxoSmithKline Plc Company Details
-
14.7.2 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product and Service
-
14.8 Synovo GmbH
-
14.8.1 Synovo GmbH Company Details
-
14.8.2 Synovo GmbH Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Synovo GmbH Mitogen Activated Protein Kinase 14 Product and Service
-
14.9 AstraZeneca Plc
-
14.9.1 AstraZeneca Plc Company Details
-
14.9.2 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product and Service
-
14.10 Chiesi Farmaceutici SpA
-
14.10.1 Chiesi Farmaceutici SpA Company Details
-
14.10.2 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Mitogen Activated Protein Kinase 14
-
Figure Mitogen Activated Protein Kinase 14 Picture
-
Table Global Mitogen Activated Protein Kinase 14 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Mitogen Activated Protein Kinase 14 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Mitogen Activated Protein Kinase 14 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Mitogen Activated Protein Kinase 14 Consumption by Country (2017-2022)
-
Figure United States Mitogen Activated Protein Kinase 14 Consumption and Growth Rate (2017-2022)
-
Table Europe Mitogen Activated Protein Kinase 14 Consumption and Growth Rate (2017-2022)
-
Figure China Mitogen Activated Protein Kinase 14 Consumption and Growth Rate (2017-2022)
-
Figure Japan Mitogen Activated Protein Kinase 14 Consumption and Growth Rate (2017-2022)
-
Figure India Mitogen Activated Protein Kinase 14 Consumption and Growth Rate (2017-2022)
-
Figure South Korea Mitogen Activated Protein Kinase 14 Consumption and Growth Rate (2017-2022)
-
Figure Global Mitogen Activated Protein Kinase 14 Consumption Forecast by Country (2022-2028)
-
Figure United States Mitogen Activated Protein Kinase 14 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Mitogen Activated Protein Kinase 14 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Mitogen Activated Protein Kinase 14 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Mitogen Activated Protein Kinase 14 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Mitogen Activated Protein Kinase 14 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Mitogen Activated Protein Kinase 14 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ralimetinib Mesylate Consumption and Growth Rate (2017-2022)
-
Figure Global Losmapimod Consumption and Growth Rate (2017-2022)
-
Figure Global Neflamapimod Consumption and Growth Rate (2017-2022)
-
Figure Global CHF-6297 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Inflammation Consumption and Growth Rate (2017-2022)
-
Figure Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
Figure Global Epithelial Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastric Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Ralimetinib Mesylate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Losmapimod Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neflamapimod Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CHF-6297 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epithelial Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Mitogen Activated Protein Kinase 14 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Mitogen Activated Protein Kinase 14 Export by Region (Top 5 Countries) (2017-2028)
-
Table Chroma Therapeutics Limited (Foundation Year, Company Profile and etc.)
-
Table Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product and Service
-
Table Toray Industries (Foundation Year, Company Profile and etc.)
-
Table Toray Industries Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Toray Industries Mitogen Activated Protein Kinase 14 Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product and Service
-
Table Zocere, Inc (Foundation Year, Company Profile and etc.)
-
Table Zocere, Inc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zocere, Inc Mitogen Activated Protein Kinase 14 Product and Service
-
Table Array BioPharma Inc (Foundation Year, Company Profile and etc.)
-
Table Array BioPharma Inc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Array BioPharma Inc Mitogen Activated Protein Kinase 14 Product and Service
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Mitogen Activated Protein Kinase 14 Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product and Service
-
Table Synovo GmbH (Foundation Year, Company Profile and etc.)
-
Table Synovo GmbH Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synovo GmbH Mitogen Activated Protein Kinase 14 Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product and Service
-
Table Chiesi Farmaceutici SpA (Foundation Year, Company Profile and etc.)
-
Table Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product and Service
-
